Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial.
Kim SI, Joung JG, Kim YN, Park J, Park E, Kim JW, Lee S, Lee JB, Kim S, Choi CH, Kim HS, Lim J, Chung J, Kim BG, Lee JY.
Kim SI, et al. Among authors: kim yn, kim bg, kim s, kim hs, kim jw.
Gynecol Oncol. 2024 Mar;182:7-14. doi: 10.1016/j.ygyno.2023.12.029. Epub 2024 Jan 20.
Gynecol Oncol. 2024.
PMID: 38246047
Clinical Trial.